Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,938 total articles
Chevron's integrated footprint, strong free cash flow and dividend yield position it to outperform during a supply-constrained oil cycle. Technical momentum and low days-to-cover support a mid-term long trade. Enter near current levels, target $205 for a 45-day swing, and protect with a $176 stop.
Waste Management (WM) recently underperformed but still trades inside a constructive range with solid fundamentals: ~$96B market cap, $3.29B in free cash flow, and a 23-year dividend growth streak. Pair those fundamentals with a fresh $3B buyback, AI-driven efficiency gains, and a resilient end-market and you have an asymmetric trade. I recommend a…
Nvidia is trading below recent highs after a sector-wide pullback. Fundamentals remain strong: a $4.985T market cap, 81.7% ROE, $119B free cash flow and an EPS of $6.59. We lay out a mid-term long trade (45 trading days) with an entry at $200.00, stop at $188.00 and a target at $260.00, backed by product catalysts around HBM4 and next-generation ar…
Yext is a sub-$1B market-cap SaaS name where product evolution around a 'Scout' intelligent search layer could re-risk growth while valuation already discounts a muted outcome. The company generates positive free cash flow ($53M last reported), carries an enterprise value of roughly $591M and trades around $5.35. This trade targets a mid-term rebou…
<p>Vistry is a classic high-beta housebuilder: if UK volumes and margins recover, upside is significant; if land and build margins deteriorate or financing costs spike, downside is sharp. This trade targets a recovery scenario while protecting capital with a defined stop.</p>
Robinhood's pullback near $100 looks like an opportunity to position for a mid-term rebound. The launch of Robinhood Chain (07/14/2026), accelerating non-crypto revenue streams and $3.01B in free cash flow give the company optionality that the market may still underprice. This trade idea gives an actionable entry, stop and target, and outlines why …
MSCI sits at the intersection of passive investing, ESG data and portfolio analytics. Its index and analytics franchises generate high-margin, recurring revenue that’s proven resilient through market cycles. Valuation is rich, but free cash flow generation and low churn offer a reliable runway. This trade idea lays out a long-biased plan with a cle…
Neuronetics (STIM) is a small-cap medical technology name with accelerating revenue drivers in transcranial magnetic stimulation (TMS) and an attractive price-to-sales of 0.74. The stock trades near $1.62 with an enterprise value of roughly $160.8M, leaving room for a re-rate if adoption and reimbursement continue to improve. However, negative marg…
Circle's core product, USDC, benefits from network effects, regulatory positioning and payments tie-ins. Competing stablecoins increase overall demand for dollar-denominated tokens rather than eroding Circle's business one-for-one. This trade idea outlines a long entry in CRCL, with strict risk controls, based on a thesis that modular growth in cus…
Ascent Industries (ACNT) is a $138M market-cap specialty-chemicals company trading at $15.29. Low debt, an enterprise value of ~$91.5M, and an EV/Sales of 1.2 give the stock room to rerate if management can convert revenue into positive free cash flow and stabilize margins. This trade targets a breakout above the 52-week high with a defined stop an…
Greenbrier offers a combination of cheap valuation (P/E ~14.5, P/B ~0.98, EV/EBITDA ~10.9) and a reliable dividend (48 consecutive quarterly payments) that creates a sizeable margin of safety for patient investors. Balance sheet liquidity and improving operating momentum argue for a long trade, while negative free cash flow and leverage represent t…
IBM plunged after a surprise weakness in its Z mainframe business, but the stock now trades near the 52-week low with a 3%+ yield, healthy free cash flow and an attractive risk/reward for long-term holders who can stomach near-term execution risk. This trade idea lays out an entry at $212.66, a stop at $198.00 and a 180-trading-day target of $280.0…
ASML sits at the center of the AI infrastructure build-out. Recent results show accelerating revenue and a 2026 guide lift to €43-45B, while management is committing to a 30% capacity increase now (with another potential 30% in 2028). That combination of structural demand and supply-constrained positioning supports a long trade with a 180-trading-d…
Assembly Biosciences (ASMB) offers a way to play a concentrated biotech bet with a strong strategic partner. With positive Phase 1b readouts for two long-acting helicase-primase inhibitors, a Gilead collaboration, and cash into 2028, the stock ($26.81) already discounts some risk but not all of the upside from Phase 2 starts and potential deal flow…
Redwire (RDW) has been punished since its late-May peak as an announced $500M at-the-market offering and sector rotation into SpaceX hammered the stock. At roughly $8.50 and a $2.02B market cap, the company still shows strong top-line momentum and a sizable backlog, while balance-sheet leverage is manageable. This is a tactical long with tight risk…
Amazon’s core secular story hasn’t changed: AWS continues to scale infrastructure revenue and margins while retail and ads provide durable cash flow. At a market cap of roughly $2.66T and a P/E near 29, the stock still prices in execution but not the next leg of AWS margin expansion. This trade idea outlines a practical long with an entry at $246.0…
Zeta Global is one of the few AI-first marketing software companies showing both rapid revenue growth and measurable free cash flow. With a market cap near $5.4B, improving technicals, a strategic Palantir partnership, and FCF of $183.8M, ZETA looks actionable on a breakout with a disciplined stop. This trade idea lays out entry, stop, targets, cat…
<p>Acco Brands (ACCO) trades at bargain multiples, throws off free cash flow of roughly $49M, and yields over 7% — metrics that argue for a constructive long trade on weakness. The company is small-cap, levered, and exposed to cyclical end markets, so position sizing and a clear stop are essential. This idea targets a measured rebound toward prior …
Santos offers asymmetric upside from exposure to LNG and Asian gas markets, advantaged low-cost production in Australia and a string of near-term growth catalysts. We outline a long-term trade with precise entry, stop and target levels, plus the key risks that could derail the thesis.
BJ's Restaurants (BJRI) has ripped to fresh 52-week highs on heavy volume, but the move is backed by solid profitability, healthy free cash flow and a conservative balance sheet. The stock looks actionable on a mid-term (45 trading days) swing with a clear entry, stop and target that balances momentum with valuation discipline.
Erasca has the science, a modality-agnostic RAS/MAPK pipeline and fresh capital. Recent legal and clinical setbacks pushed sentiment into the gutter; that creates a trading opportunity for investors willing to take event risk. This trade targets a mid-term recovery if the company executes on clinical updates and the patent dispute does not derail d…
XPO's operational rebound in North American LTL, durable free cash flow, and visible AI-driven productivity gains make it a constructive long-term trade. Valuation is not cheap, but the combination of improving operating ratios, a $456M free cash flow run-rate and bullish technicals supports a long entry at current levels for a 180-trading-day hori…
Merck (MRK) is a Strong Buy on expectation of a near-term regulatory milestone for its new oncology candidate Lipfendra and continued commercialization of its oncology portfolio. The stock offers a compelling mix of steady cash generation (free cash flow $14.1B), a $315B market cap, and an established commercial engine. We lay out a clear entry, st…
<p>Q2 Holdings' share-price damage feels overstated relative to its fundamentals. The company has moved customers to the cloud, is producing positive free cash flow, and still grows revenue double digits — yet the stock trades nearer its 52-week low than its highs. This trade idea lays out a concrete long entry, stop and target with a clear 180-tra…
Micron’s pullback from its 52-week high has created a defined risk / reward for a mid-term swing. Strong profitability, massive free cash flow, and constrained supply for high-bandwidth memory underpin the bullish case, while sector-level volatility and bearish technicals argue for a disciplined entry, tight stop, and realistic target.
